Amgen Inc. Stock Slides 10.1%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Amgen Inc. tumbled 10.1% to $393.17 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,673.52 and Dow Jones Industrial Average falling 1.2% to 52,786.07.

This was the stock's second consecutive day of losses.

Amgen Inc. closed 12.0% below its 52-week high of $447.03, which the company achieved on August 25th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $269.12, Pfizer Inc. fell 2.3% to $27.79, and AbbVie Inc. fell 2.99% to $248.78.

Trading volume totaled 6.5 million, compared to the 50-day average of 2.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 08, 2026 16:33 ET (20:33 GMT)